• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种乳腺癌和卵巢癌易感基因BRCA1的有力候选基因。

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

作者信息

Miki Y, Swensen J, Shattuck-Eidens D, Futreal P A, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett L M, Ding W

机构信息

Department of Medical Informatics, University of Utah Medical Center, Salt Lake City 84132.

出版信息

Science. 1994 Oct 7;266(5182):66-71. doi: 10.1126/science.7545954.

DOI:10.1126/science.7545954
PMID:7545954
Abstract

A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and ovarian cancer, has been identified by positional cloning methods. Probable predisposing mutations have been detected in five of eight kindreds presumed to segregate BRCA1 susceptibility alleles. The mutations include an 11-base pair deletion, a 1-base pair insertion, a stop codon, a missense substitution, and an inferred regulatory mutation. The BRCA1 gene is expressed in numerous tissues, including breast and ovary, and encodes a predicted protein of 1863 amino acids. This protein contains a zinc finger domain in its amino-terminal region, but is otherwise unrelated to previously described proteins. Identification of BRCA1 should facilitate early diagnosis of breast and ovarian cancer susceptibility in some individuals as well as a better understanding of breast cancer biology.

摘要

通过定位克隆方法,已鉴定出一个与17号染色体连锁的BRCA1基因的有力候选基因,该基因影响乳腺癌和卵巢癌的易感性。在八个推测分离BRCA1易感等位基因的家族中,有五个检测到可能的致病突变。这些突变包括一个11个碱基对的缺失、一个1个碱基对的插入、一个终止密码子、一个错义替代以及一个推断的调控突变。BRCA1基因在包括乳腺和卵巢在内的许多组织中表达,并编码一种预测的含1863个氨基酸的蛋白质。该蛋白质在其氨基末端区域含有一个锌指结构域,但在其他方面与先前描述的蛋白质无关。BRCA1的鉴定应有助于某些个体乳腺癌和卵巢癌易感性的早期诊断,以及更好地理解乳腺癌生物学。

相似文献

1
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.一种乳腺癌和卵巢癌易感基因BRCA1的有力候选基因。
Science. 1994 Oct 7;266(5182):66-71. doi: 10.1126/science.7545954.
2
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.瑞典南部遗传性乳腺癌和卵巢癌中BRCA1基因的奠基性突变
Am J Hum Genet. 1996 Mar;58(3):441-50.
3
BRCA1 mutations in primary breast and ovarian carcinomas.原发性乳腺癌和卵巢癌中的BRCA1基因突变。
Science. 1994 Oct 7;266(5182):120-2. doi: 10.1126/science.7939630.
4
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.20个乳腺癌-卵巢癌家族中BRCA1突变的高发生率。
Am J Hum Genet. 1996 Jan;58(1):42-51.
5
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.携带BRCA1基因突变者的乳腺癌和卵巢癌发病率。乳腺癌连锁协会。
Am J Hum Genet. 1995 Jan;56(1):265-71.
6
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.加拿大乳腺癌和卵巢癌家族中BRCA1突变的共同起源。
Nat Genet. 1994 Dec;8(4):392-8. doi: 10.1038/ng1294-392.
7
Has the breast cancer gene been found?乳腺癌基因被发现了吗?
Cell. 1994 Oct 7;79(1):1-3. doi: 10.1016/0092-8674(94)90393-x.
8
BRCA1 and prostate cancer.乳腺癌1号基因(BRCA1)与前列腺癌
Cancer Invest. 2001;19(4):396-412. doi: 10.1081/cnv-100103134.
9
Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.通过分析十个家庭中与乳腺癌和卵巢癌相关的种系突变来确认BRCA1。
Nat Genet. 1994 Dec;8(4):399-404. doi: 10.1038/ng1294-399.
10
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.在10个乳腺癌/卵巢癌家族中检测到8种BRCA1突变,其中包括1个患有男性乳腺癌的家族。
Am J Hum Genet. 1995 Jul;57(1):1-7.

引用本文的文献

1
Redefining Risk, Biomarkers, and Precision Therapy for Hereditary Ovarian Cancer: A Review.重新定义遗传性卵巢癌的风险、生物标志物和精准治疗:综述
ACS Omega. 2025 Aug 16;10(33):36890-36903. doi: 10.1021/acsomega.5c05260. eCollection 2025 Aug 26.
2
Increasing pathogenic germline variant diagnosis rates in precision medicine: current best practices and future opportunities.提高精准医学中致病种系变异的诊断率:当前最佳实践与未来机遇
Hum Genomics. 2025 Aug 22;19(1):97. doi: 10.1186/s40246-025-00811-z.
3
BRCA1 and BRCA2 gene expression: p53- and cell cycle-dependent repression requires RB and DREAM.
BRCA1和BRCA2基因表达:p53和细胞周期依赖性抑制需要RB和DREAM。
Cell Death Differ. 2025 Aug 22. doi: 10.1038/s41418-025-01566-9.
4
Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women.全外显子组测序确定FANCM是西班牙裔/拉丁裔女性雌激素受体阴性乳腺癌的一个易感基因。
Nat Commun. 2025 Aug 21;16(1):7816. doi: 10.1038/s41467-025-60564-0.
5
Hotspots and future trends of male breast cancer: a global perspective.男性乳腺癌的热点问题与未来趋势:全球视角
Clin Transl Oncol. 2025 Aug 21. doi: 10.1007/s12094-025-04026-5.
6
Proteogenomic characterization of invasive breast tumors in young women.年轻女性浸润性乳腺癌的蛋白质基因组特征分析
NPJ Breast Cancer. 2025 Aug 18;11(1):94. doi: 10.1038/s41523-025-00793-0.
7
Prostate cancer germline variants with therapeutic implications.具有治疗意义的前列腺癌种系变异
Trends Mol Med. 2025 Jul 30. doi: 10.1016/j.molmed.2025.07.004.
8
Current insights into breast and ovarian cancer risk: a contemporary review.乳腺癌和卵巢癌风险的当前见解:一项当代综述。
Minerva Surg. 2025 Aug;80(4):334-353. doi: 10.23736/S2724-5691.25.10651-5.
9
Real-World Impact of a BRCA Testing Protocol in Portugal.葡萄牙BRCA检测方案的真实世界影响
Cureus. 2025 Jun 25;17(6):e86732. doi: 10.7759/cureus.86732. eCollection 2025 Jun.
10
Inherited Susceptibility to Cancer: Past, Present and Future.癌症的遗传易感性:过去、现在与未来
Ann Hum Genet. 2025 Sep;89(5):354-365. doi: 10.1111/ahg.70013. Epub 2025 Jul 21.